Sherwin-Williams
SHW
$344.32
+0.01%
The Sherwin-Williams Company is the world's largest manufacturer of paints and coatings, operating across three primary segments: a vast network of over 4,800 company-owned stores (Paint Stores Group), branded architectural paints sold through big-box retailers (Consumer Brands Group), and specialized industrial coatings (Performance Coatings Group). As the dominant market leader in its industry, the company is distinguished by its unparalleled vertical integration and direct-to-professional distribution model, which provides a significant competitive moat. The current investor narrative centers on the company's resilience as a dividend aristocrat, with recent news highlighting its 47th consecutive annual dividend increase, while debates focus on its ability to navigate potential cyclical headwinds in the housing and industrial end-markets and sustain its premium valuation.…
SHW
Sherwin-Williams
$344.32
Related headlines
Investment Opinion: Should I buy SHW Today?
Rating: Hold. The core thesis is that Sherwin-Williams is a high-quality company with a durable moat, but its premium valuation and cyclical exposure create an unfavorable near-term risk/reward profile, warranting patience for a better entry point.
Supporting evidence includes a forward P/E of 25.97x, which is elevated for a cyclical business, and revenue growth that has decelerated to 5.64% YoY in Q4. While profitability remains strong with a gross margin of 48.84% and free cash flow generation is excellent at $2.65B TTM, the stock's 1-year performance of +0.64% massively underperforms the S&P 500 (+19.14%), indicating market skepticism. The unanimous bullish analyst sentiment (9 out of 9 'Buy'/'Outperform') provides a contrarian signal that the stock may be fully valued.
The thesis would upgrade to a Buy if the forward P/E compresses toward 20x, offering a larger margin of safety, or if quarterly revenue growth re-accelerates above 7% with gross margins stabilizing above 49%. It would downgrade to a Sell if revenue growth turns negative or if the debt-to-equity ratio escalates meaningfully above 3.2. Based on the current data, the stock is considered fairly valued to slightly overvalued relative to its near-term cyclical risks, despite its long-term quality.
Sign up to view all
SHW 12-Month Price Forecast
The AI assessment is neutral based on a clash between high-quality fundamentals and concerning macro/valuation signals. Sherwin-Williams possesses an exceptional business model and financial discipline, as shown by its 47-year dividend growth streak and robust cash flow. However, the stock's premium valuation appears precarious given the cyclical nature of its end-markets, recent margin pressure, and its dramatic underperformance versus the broader market. The stance would upgrade to bullish on a meaningful pullback towards the $300-$320 range (compressing the forward P/E) or clear evidence of re-accelerating growth and margin expansion. It would turn bearish if the company fails to defend its 48%+ gross margin or if housing data deteriorates significantly.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Sherwin-Williams's 12-month outlook, with a consensus price target around $447.62 and implied upside of +30.0% versus the current price.
Average Target
$447.62
9 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
9
covering this stock
Price Range
$275 - $448
Analyst target range
The stock is covered by 9 analysts, and recent institutional ratings from firms like Mizuho, RBC Capital, and UBS consistently show 'Outperform' or 'Buy' actions, indicating a bullish consensus sentiment. While the exact average target price and implied upside are not provided in the data, the pattern of recent analyst actions—including an upgrade from Citigroup from 'Neutral' to 'Buy' in December 2025—points to strengthening conviction among coverage firms. The absence of a specific target range in the data limits a detailed discussion of high and low case assumptions; however, the consistent 'Outperform' ratings suggest analysts believe in the company's ability to execute its strategy and deliver on growth expectations, with the primary debate likely revolving around the pace of margin recovery and cyclical demand rather than the fundamental business model.
Bulls vs Bears: SHW Investment Factors
The bull case, anchored by Sherwin-Williams' formidable competitive moat, strong cash generation, and unanimous analyst support, currently holds stronger evidence for the long-term investor. However, the bear case presents a compelling near-term caution due to the stock's premium valuation juxtaposed against cyclical risks, financial leverage, and recent margin pressure. The single most important tension in the investment debate is whether the company's industry-leading position and direct distribution model justify its high valuation multiples (forward P/E of 25.97x) in the face of a potential economic slowdown that could pressure its core housing and industrial end-markets. The resolution of this tension—specifically, the trajectory of gross margins and revenue growth in upcoming quarters—will most decisively shift the thesis.
Bullish
- Unmatched Vertical Integration & Moat: Sherwin-Williams operates over 4,800 company-owned stores, creating a direct-to-professional distribution network that competitors cannot easily replicate. This vertical integration provides a significant competitive moat, driving customer loyalty and pricing power, as evidenced by its robust 48.84% gross margin in Q4 2025.
- Strong Free Cash Flow Generation: The company generates substantial cash, with trailing twelve-month free cash flow of $2.65 billion. This provides ample internal funding for dividends, share repurchases, and strategic investments, supporting its 47th consecutive annual dividend increase and reinforcing its status as a reliable dividend aristocrat.
- Analyst Consensus Bullishness: All 9 covering analysts maintain 'Outperform' or 'Buy' ratings, with recent actions including an upgrade from Citigroup. This unanimous bullish sentiment indicates strong institutional conviction in the company's strategy and execution, despite cyclical concerns.
- Recent Technical Momentum Reversal: The stock is up 11.00% over the past month, sharply diverging from its flat annual performance. This suggests a potential bullish reversal or mean reversion after a period of underperformance, with the price now positioned in the upper-mid portion of its 52-week range.
Bearish
- Premium Valuation with Cyclical Risk: The stock trades at a forward P/E of 25.97x and an EV/EBITDA of 21.42x, which are elevated multiples for a cyclical business. This premium valuation is vulnerable to compression if housing or industrial end-markets soften, as suggested by the sequential deceleration in Q4 revenue growth to 5.64% YoY.
- Significant Financial Leverage: The company carries a high debt-to-equity ratio of 3.16, indicating a leveraged balance sheet. Coupled with a current ratio of 0.87, this creates financial risk in a rising interest rate environment, potentially pressuring earnings through higher interest expenses.
- Margin Compression & Earnings Volatility: Gross margin compressed from 49.16% in Q3 2025 to 48.84% in Q4 2025, indicating pressure from input costs or product mix. Net income also showed significant quarterly volatility, dropping from $833.1M in Q3 to $476.8M in Q4, highlighting earnings sensitivity.
- Chronic Underperformance vs. Market: Over the past year, SHW gained only 0.64%, dramatically underperforming the S&P 500's 19.14% gain. This -18.5% relative strength deficit indicates the market has been discounting its cyclical exposure and premium valuation despite its strong business model.
SHW Technical Analysis
The stock is in a volatile, range-bound consolidation phase, with a 1-year price change of only 0.64%, significantly underperforming the S&P 500's 19.14% gain over the same period. Currently trading at $344.07, the price sits at approximately 71% of its 52-week range ($289.86 to $379.65), indicating it is positioned in the upper-mid portion of its annual band, suggesting neither extreme momentum nor deep value. Recent momentum shows a notable short-term recovery, with the stock up 11.00% over the past month and 9.10% over the past three months, sharply diverging from its flat annual performance and potentially signaling a bullish reversal or mean reversion after a period of weakness. Key technical levels are clearly defined by the 52-week high of $379.65 as major resistance and the 52-week low of $289.86 as critical support; a decisive breakout above resistance would signal a resumption of the longer-term uptrend, while a breakdown below support could indicate a deeper correction. With a beta of 1.126, the stock exhibits approximately 13% more volatility than the broader market, which is a relevant consideration for risk management, especially given its recent maximum drawdown of -21.91%.
Beta
1.13
1.13x market volatility
Max Drawdown
-21.9%
Largest decline past year
52-Week Range
$290-$380
Price range past year
Annual Return
+0.3%
Cumulative gain past year
| Period | SHW Return | S&P 500 |
|---|---|---|
| 1m | +13.3% | -1.3% |
| 3m | +5.7% | +14.0% |
| 6m | +6.3% | +9.5% |
| 1y | +0.3% | +20.9% |
| ytd | +5.0% | +9.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SHW Fundamental Analysis
Revenue growth has been modest but positive, with Q4 2025 revenue of $5.60 billion representing a 5.64% year-over-year increase; however, examining the quarterly trend reveals a sequential deceleration from higher growth rates in prior quarters, suggesting a normalization of demand. The company remains solidly profitable, posting Q4 2025 net income of $476.8 million with a robust gross margin of 48.84%, though this margin has compressed slightly from the 49.16% reported in Q3 2025, indicating potential pressure from input costs or mix shifts. Financial health is characterized by strong cash generation but significant leverage, with trailing twelve-month free cash flow of $2.65 billion providing ample internal funding, yet a debt-to-equity ratio of 3.16 and a current ratio of 0.87 highlight a leveraged balance sheet and relatively tight short-term liquidity, which is typical for the capital-intensive nature of the business but warrants monitoring in a rising rate environment.
Quarterly Revenue
$5.6B
2025-12
Revenue YoY Growth
+0.05%
YoY Comparison
Gross Margin
+0.48%
Latest Quarter
Free Cash Flow
$2.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SHW Overvalued?
Given the company's consistent profitability with a positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio stands at 31.22x, while the forward PE is 25.97x; the forward multiple's discount to the trailing figure implies the market anticipates earnings growth and a moderation from current elevated levels. Compared to sector averages (data not available in the provided dataset for a direct comparison), Sherwin-Williams' valuation cannot be precisely benchmarked, but its high absolute multiples suggest the market prices in its industry-leading position, stable margins, and dividend aristocrat status, potentially justifying a premium. Historically, the stock's current trailing PE of 31.22x is below its recent peak levels seen in late 2024 (e.g., 44.73x at the end of 2024) but above the lows of the past few years, positioning it in the mid-to-upper range of its own historical band and indicating that while not at peak optimism, expectations remain relatively high.
PE
31.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 19x~75x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
21.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks stem primarily from the company's leveraged balance sheet and earnings volatility. The debt-to-equity ratio of 3.16 is high, and the current ratio of 0.87 indicates tight short-term liquidity, which could strain operations if financing costs rise further. Furthermore, net income demonstrated high quarterly volatility, falling 43% from Q3 to Q4 2025, and gross margin compression from 49.16% to 48.84% in the same period signals vulnerability to input cost inflation or unfavorable sales mix, threatening the premium valuation built on stable profitability.
Market & Competitive Risks are dominated by valuation compression. Trading at a forward P/E of 25.97x and an EV/EBITDA of 21.42x, the stock carries a significant premium that is historically afforded to stable growth, not cyclical companies. A beta of 1.126 confirms above-market volatility, making the stock susceptible to sector rotations away from cyclicals during economic uncertainty. The primary external threat is a downturn in the housing and industrial sectors, which would directly impact demand across all three of Sherwin-Williams' segments and likely trigger multiple contraction.
The Worst-Case Scenario involves a pronounced cyclical downturn coinciding with sustained input cost inflation. This one-two punch would compress gross margins below 48%, trigger earnings misses, and lead to analyst downgrades. The resulting de-rating could see the stock re-test its 52-week low of $289.86, representing a potential downside of approximately -16% from the current price of $344.07. A more severe scenario, incorporating the stock's maximum drawdown of -21.91%, suggests a plausible downside risk to the ~$269 level, or a loss of over -20% for investors.
FAQ
The key risks are, in order of severity: 1) Valuation & Cyclical Risk: A premium forward P/E of 25.97x is vulnerable to compression if housing or industrial demand weakens. 2) Financial Risk: High debt-to-equity (3.16) and tight liquidity (current ratio 0.87) increase vulnerability to rising interest rates. 3) Operational Risk: Recent gross margin compression (Q4: 48.84% vs. Q3: 49.16%) indicates sensitivity to input costs, and quarterly earnings are volatile (net income fell 43% QoQ). 4) Market Risk: The stock's beta of 1.126 means it is 13% more volatile than the market, and it has significantly underperformed the S&P 500 over the past year.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $340 and $370, assuming modest economic growth and the company meeting consensus EPS estimates. The Bull Case (25% probability) targets $379 to $400, driven by economic resilience and margin expansion. The Bear Case (15% probability) warns of a drop to $290-$320 if a recession hits cyclical demand. The Base Case is most likely, anchored by the company's strong moat and cash flow, but constrained by its elevated valuation which limits near-term upside absent a perfect economic backdrop.
SHW appears fairly valued to slightly overvalued based on its current cyclical positioning. The forward P/E of 25.97x and EV/EBITDA of 21.42x are premium multiples, historically justified by its market leadership and stable margins. However, with Q4 revenue growth decelerating to 5.64% YoY and gross margin showing signs of compression, the market is paying for stability that may be at risk. Compared to its own history, the trailing P/E of 31.22x is below its late-2024 peak of 44.73x but still in the mid-to-upper range, suggesting the valuation implies a 'soft landing' economic scenario that may not materialize.
SHW is a good buy for long-term investors seeking a high-quality, dividend-growing company, but timing is crucial. At its current forward P/E of 25.97x and after a recent 11% monthly rally, the near-term risk/reward is balanced to slightly unfavorable. The unanimous bullish analyst sentiment suggests the positive story is well-known, while the stock's -18.5% underperformance vs. the S&P 500 over the past year indicates persistent skepticism. It becomes a more compelling buy on a pullback towards $320, which would offer a better margin of safety against its cyclical risks and high financial leverage (D/E of 3.16).
SHW is unequivocally suitable for long-term investment, with a suggested minimum holding period of 3-5 years. Its status as a Dividend Aristocrat with 47 consecutive annual increases is built for compounding returns over time. The stock's beta of 1.126 and recent maximum drawdown of -21.91% make it unsuitable for short-term trading, as cyclical volatility can lead to significant swings. Long-term investors can look through economic cycles to capture the value of its unparalleled distribution network and market leadership, while using dividend reinvestment to average into the position.